FDA-Drug2026-09-02Class IICHEMICAL

Accord Healthcare levothyroxine sodium tablets recalled for subpotent drug

LABEL MIX UPNationwide distributionDrugs

What this means

Accord Healthcare is recalling specific lots of levothyroxine sodium tablets (25 mcg) because they contain less active ingredient than labeled. Patients taking these tablets may not receive the full dose needed to manage their thyroid condition. The affected lots were distributed nationwide.

  • Check your levothyroxine bottle for lot number D2401927, D2401833, D2402551, D2402552, D2500220, or D2500223.
  • Contact your pharmacy or doctor immediately if you have one of these lots.
  • Do not stop taking your levothyroxine without talking to your doctor first.
  • Your doctor may need to verify your dose or switch you to a new bottle.
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Subpotent Drug

Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the United States
Affected count
N/A
Manufactured in
8041 Arco Corporate Dr Ste 200, N/A, Raleigh, NC, United States
Products
Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-447-17.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0775-2026

More Accord Healthcare recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.